Wolverine Asset Management’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Wolverine Asset Management’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,369	Closed	-$44.7K	–	2422
2022 Q4	$44.7K	Sell	4,369 -12	-0.3%	-$121	﹤0.01%	1401
2022 Q3	$44K	Sell	4,381 -1	-0%	-$10	﹤0.01%	1633
2022 Q2	$43K	Buy	+4,382	New	+$44.1K	﹤0.01%	1610

Other funds holding LVACU

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Wolverine Asset Management's LVACU Position: Q1 2023 in Review

Wolverine Asset Management sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q1 2023, closing a stake of 4,369 shares — an estimated $44.7K sold.

Wolverine Asset Management first reported a position in LVACU in Q2 2022 and held it in 3 quarters. The position peaked at $44.7K in Q4 2022. 4 funds tracked by Wall St. Rank hold LVACU as of Q1 2023.

Wolverine Asset Management reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 4,369 LAVA Medtech Acquisition Corp. Unit shares in Q1 2023, an estimated $44.7K.
Wolverine Asset Management first reported a position in LAVA Medtech Acquisition Corp. Unit in Q2 2022 and held it in 3 quarters.
Wolverine Asset Management's LAVA Medtech Acquisition Corp. Unit position peaked at $44.7K in Q4 2022.
4 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.